Literature DB >> 24554829

Severe Aplastic Anemia Manifesting After Complete Remission of Acute Promyelocytic Leukemia: Is it a Fortuitous Association?

Rajeshwari Satish Handigund1, Prakash R Malur2, Annasaheb J Dhumale3, Akshay Bali4, Maitrayee Roy4, Suvarna Inumella2.   

Abstract

Acute leukemia, secondary myelodysplasia and paroxysmal nocturnal hemoglobinuria evolving from severe aplastic anemia (AA) following immunosuppressive therapy are well recognized. However, severe AA occurring after complete remission of acute promyelocytic leukemia (APL) has been documented only once in 2009. We report a case of 30-year-old male diagnosed with APL who achieved complete cytogenetic remission with all-trans retinoic acid based induction regimen and developed severe AA few months later during maintenance therapy.

Entities:  

Keywords:  ATRA; Acute promyelocytic leukemia; Severe aplastic anemia

Year:  2012        PMID： 24554829      PMCID： PMC3921322          DOI： 10.1007/s12288-012-0201-8

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  14 in total

1.  First reported case of aplastic anemia occurring in a patient after acute promyelocytic leukemia in remission.

Authors:  Alexander Pham; Bahareh Bahadini; Randa Alsabeh; Amir Steinberg
Journal:  Clin Adv Hematol Oncol       Date:  2009-10

2.  Aplastic anemia surfacing after treatment of acute promyelocytic leukemia: The Dameshek riddle.

Authors:  Chadi Nabhan; Abhilasha Radhakrishnan
Journal:  Clin Adv Hematol Oncol       Date:  2009-10

3.  Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant.

Authors:  Zeba N Singh; Dezheng Huo; John Anastasi; Sonali M Smith; Theodore Karrison; Michelle M Le Beau; Richard A Larson; James W Vardiman
Journal:  Am J Clin Pathol       Date:  2007-02       Impact factor: 2.493

4.  Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and "hypoplastic" leukemia have in common?

Authors:  W Dameshek
Journal:  Blood       Date:  1967-08       Impact factor: 22.113

Review 5.  Acquired aplastic anemia.

Authors:  Neal S Young
Journal:  Ann Intern Med       Date:  2002-04-02       Impact factor: 25.391

Review 6.  Acute promyelocytic leukemia: from highly fatal to highly curable.

Authors:  Zhen-Yi Wang; Zhu Chen
Journal:  Blood       Date:  2008-03-01       Impact factor: 22.113

Review 7.  Riddle: what do aplastic anemia, acute promyelocytic leukemia, and chronic myeloid leukemia have in common?

Authors:  R A Brodsky; R J Jones
Journal:  Leukemia       Date:  2004-10       Impact factor: 11.528

8.  Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.

Authors:  I Lobe; F Rigal-Huguet; A Vekhoff; B Desablens; D Bordessoule; C Mounier; A Ferrant; M Sanz; M Fey; C Chomienne; S Chevret; L Degos; P Fenaux
Journal:  Leukemia       Date:  2003-08       Impact factor: 11.528

9.  All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

Authors:  Martin S Tallman; Janet W Andersen; Charles A Schiffer; Frederick R Appelbaum; James H Feusner; William G Woods; Angela Ogden; Howard Weinstein; Lois Shepherd; Cheryl Willman; Clara D Bloomfield; Jacob M Rowe; Peter H Wiernik
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

Review 10.  Acquired immune mediated aplastic anemia: is it antineoplastic?

Authors:  Catherine Nissen; Martin Stern
Journal:  Autoimmun Rev       Date:  2009-02-24       Impact factor: 9.754
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.